Cargando…

Toward understanding the genetics of regulatory T cells in ovarian cancer

Tumor-infiltrating regulatory T cells (Tregs) promote immune evasion and are associated with poor disease outcome in patients affected by various malignancies. We have recently demonstrated that several, inherited single nucleotide polymorphisms affecting Treg-related genes influence the survival of...

Descripción completa

Detalles Bibliográficos
Autores principales:	DeRycke, Melissa S, Charbonneau, Bridget, Preston, Claudia C, Kalli, Kimberly R, Knutson, Keith L, Rider, David N, Goode, Ellen L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716752/ https://www.ncbi.nlm.nih.gov/pubmed/23894717 http://dx.doi.org/10.4161/onci.24535

Ejemplares similares

The Ratios of CD8(+) T Cells to CD4(+)CD25(+) FOXP3(+) and FOXP3(-) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
por: Preston, Claudia C., et al.
Publicado: (2013)

Targeting the right regulatory T-cell population for tumor immunotherapy
por: Weiss, Vivian L., et al.
Publicado: (2012)

The two faces of regulatory T cells in cancer
por: Blatner, Nichole R, et al.
Publicado: (2013)

BIM-EL localization: The key to understanding anoikis resistance in inflammatory breast cancer cells
por: Buchheit, Cassandra L, et al.
Publicado: (2015)

Hunting for clues: Regulatory T cells and colorectal cancer
por: Gallimore, Awen, et al.
Publicado: (2012)

Dendritic cell-based immunotherapy in ovarian cancer
por: Coosemans, An, et al.
Publicado: (2013)

A new strategy to target regulatory T cells in solid tumors
por: Thomas-Schoemann, Audrey, et al.
Publicado: (2013)

Neuropilin 1 guides regulatory T cells into VEGF-producing melanoma
por: Hansen, Wiebke
Publicado: (2013)

Understanding anti-leukemia responses to donor lymphocyte infusion
por: Bachireddy, Pavan, et al.
Publicado: (2014)

‘Hardcore’ OX40(+) immunosuppressive regulatory T cells in hepatic cirrhosis and cancer
por: Piconese, Silvia, et al.
Publicado: (2014)

Contribution of regulatory T cells to immunosuppression and disease progression in multiple myeloma patients
por: Raja, Karthick Raja Muthu, et al.
Publicado: (2013)

Interleukin-2 treatment of tumor patients can expand regulatory T cells
por: Beyer, Marc
Publicado: (2012)

Activin A backs-up TGF-ß to promote regulatory T cells
por: De Martino, Mara, et al.
Publicado: (2021)

Tumor vascularity in ovarian cancer: T cells need breathing room
por: Neilson, David, et al.
Publicado: (2014)

Know thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?
por: Facciabene, Andrea, et al.
Publicado: (2012)

Plasmacytoid dendritic cells and regulatory T cells in the tumor microenvironment: A dangerous liaison
por: Conrad, Curdin, et al.
Publicado: (2013)

Organ-specific regulatory T cells of thymic origin are expanded in murine prostate tumors
por: Malchow, Sven, et al.
Publicado: (2013)

Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody
por: Choi, Bryan D, et al.
Publicado: (2013)

Regulatory mechanisms of nucleic acid-mediated innate immune responses in the tumor microenvironment
por: Jinushi, Masahisa
Publicado: (2012)

IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer
por: Lunardi, Serena, et al.
Publicado: (2015)

C3G self-regulatory mechanism revealed: implications for hematopoietic malignancies
por: Carabias, Arturo, et al.
Publicado: (2020)

Understanding the influence of the tumor microenvironment on macrophage responses to CD40 agonists
por: Luheshi, Nadia, et al.
Publicado: (2014)

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis
por: Labidi-Galy, Sana Intidhar, et al.
Publicado: (2012)

Dendritic cells matured in the presence of TLR ligands overcome the immunosuppressive functions of regulatory T cells
por: Berk, Erik, et al.
Publicado: (2014)

VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer
por: Terme, Magali, et al.
Publicado: (2013)

Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy
por: Shen, Li, et al.
Publicado: (2012)

T-cell suppression mediated by regulatory T cells infiltrating hepatic tumors can be overcome by GITRL treatment
por: Pedroza-Gonzalez, Alexander, et al.
Publicado: (2013)

Toward a rational design of combination therapy in cancer
por: Doucey, Marie-Agnès, et al.
Publicado: (2015)

BRCA1: a movement toward cancer prevention
por: Alli, Elizabeth, et al.
Publicado: (2015)

Bone marrow provides an environment that prevents suppression of therapeutic graft-vs.-tumor immunity by regulatory T cells
por: Guichelaar, Teun, et al.
Publicado: (2013)

Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma
por: Brown, Ross, et al.
Publicado: (2012)

Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth
por: Fujimura, Taku, et al.
Publicado: (2012)

Effector memory regulatory T-cell expansion marks a pivotal point of immune escape in myelodysplastic syndromes
por: Mailloux, Adam W., et al.
Publicado: (2013)

Retinoic acid-producing DCs and gut-tropic FOXP3(+) regulatory T cells in the induction of oral tolerance
por: Villablanca, Eduardo J.
Publicado: (2013)

Oncogenic regulatory circuits driven by 19q13 rs11672691 underlies prostate cancer aggressiveness
por: Xia, Ji-Han, et al.
Publicado: (2018)

Extracellular vesicles released by ovarian carcinoma contain arginase 1 that mitigates antitumor immune response
por: Sosnowska, Anna, et al.
Publicado: (2019)

CX-5461 can destabilize replication forks in PARP inhibitor-resistant models of ovarian cancer
por: Xuan, Jiachen, et al.
Publicado: (2020)

BRAF inhibitors in colorectal cancer: Toward a differentiation therapy?
por: Herr, Ricarda, et al.
Publicado: (2015)

The consensus immunoscore: toward a new classification of colorectal cancer
por: Lanzi, Anastasia, et al.
Publicado: (2020)

Regulatory T cells do not suppress rather activate human basophils by IL-3 and STAT5-dependent mechanisms
por: Das, Mrinmoy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pcoaa1a5nkr7s6slutbnk252gp